Printer Friendly

Browse Nitisinone topic

Articles

1-15 out of 15 article(s)
Title Author Type Date Words
Weedkiller could help thousands suffering from 'black bone disease'. Dec 5, 2020 484
Par Pharmaceutical. Sep 21, 2020 290
'My baby daughter's black wee was the first clue to her incurable disease' Sophia Hajnorouzi, 4, is a seemingly healthy little girl about to start school, but thanks to a rare genetic disorder a cruel fate awaits her when she hits 18. Sep 13, 2020 1308
Cycle Pharmaceuticals announces USD25m debt financing; Varsity incorporated as independent synthetic oncology research business. Sep 8, 2020 184
Cycle Pharmaceuticals announces USD25m debt financing; Varsity incorporated as independent synthetic oncology research business. Sep 8, 2020 188
A challenging case of hereditary type 1 tyrosinaemia associated with persistent diarrhoea: Case report and literature review. Yassin, N.A.; Mogahed, E.A.; El-Karaksy, H. Jun 1, 2020 1858
Child with Discrepant Urine Protein Results. Vaudran, Lucie; Schraen, Susanna; Kim, Isabelle; Dessein, Anne-Frederique; Onraed, Brigitte Nov 1, 2019 575
US FDA grants approval to Novitium Pharma's Biovitrum's Orfadin. Sep 6, 2019 115
US FDA grants approval to Novitium Pharma's Biovitrum's Orfadin. Sep 6, 2019 111
Endo reports FDA approval for first generic Orfadin. Sep 5, 2019 176
Endo reports FDA approval for first generic Orfadin. Sep 5, 2019 172
Poly(lactic-co-glycolic acid) Nanoparticles Loaded with Callistemon citrinus Phenolics Exhibited Anticancer Properties against Three Breast Cancer Cell Lines. Ahmed, Rashid; Tariq, Muhammad; Ahmad, Irian S.; Fouly, Hanafy; Fakhar-i-Abbas; Hasan, Anwarul; Kush Jul 31, 2019 7083
Musculoskeletal manifestations of alkaptonuria: A case report and literature review. Wu, Katherine; Bauer, Erin; Myung, Gihyun; Fang, Meika A. Clinical report Apr 23, 2019 3246
A Comprehensive LC-QTOF-MS Metabolic Phenotyping Strategy: Application to Alkaptonuria. Norman, Brendan P.; Davison, Andrew S.; Ross, Gordon A.; Milan, Anna M.; Hughes, Andrew T.; Sutherla Apr 1, 2019 6050
Tyrosinemia Type I and Reversible Neurogenic Crisis After a One-Month Interruption of Nitisinone. Yazici, Havva; Canda, Ebru; Er, Esra; Kilinc, Mehmet Arda; Ucar, Sema Kalkan; Karapinar, Bulent; Cok Clinical report Mar 1, 2018 1724

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |